EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Addus HomeCare Corporation
ADUS

ADUS Addus HomeCare Corporation

Addus HomeCare Corporation · NASDAQ
Market Closed
117.09
▼ ⁦-1.21%⁩ (-1.43)
Market Cap$2.2B
Beta0.86
52w Low52w High
87.95124.44
Last Week
⁦-0.91%⁩
Last Month
⁦-2.16%⁩
Last 3 Months
⁦+25.19%⁩
Last Year
⁦+2.58%⁩
EL7 Factor Analysis
How we score this
Overall96
Excellent — top fifth of the marketSuper StockF 7/9SafeBetter than 96% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
64
20.5x▼17.8xAround median
▸
Growth
73
15.9%▲7.1%Top tier
▸
Quality
64
9.0%▲4.5%Around median
▸
Safety
92
0.1x▲2.6xTop tier
▸
Capital Return
87
—2.12%Top tier
▸
Momentum
75
1.8%▼2.9%Top tier
▸
Sentiment
61
9▲3Around median
Fair Value
Current price$117
Analyst target · 4 analysts
$115
⁦-2%⁩
See it fairly priced
Range ⁦$96–$134⁩
vs
DCF (estimate)
$141
⁦+21%⁩
Sees it clearly undervalued
⁦8.2⁩% discount · ⁦2⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$115–$141⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 4 analysts setting price target
$115.00
⁦-1.8%⁩
Current Price $117.09·Median $115.00
Low
$96.00
High
$134.00
Current price
$117.09
Average target
$115.00
Street summary

Addus HomeCare (ADUS) Price Target Analysis

ADUS shares saw a 2.13% decline in the average price target over the past 30 days, with the consensus settling at $115, a level slightly below the current trading price of $115.55. A decrease in the number of analysts contributing to price targets was also recorded, falling from 6 to 4 analysts over the last 24 hours, indicating a contraction in direct coverage or a revision in valuation methodologies.

As of 2026-08-28
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 3.93
Buy
Analyst coverage
⁦14 (-2)⁩
Buy conviction
86%
High
Target dispersion
32%
Wide
Analyst ratings over time14 analysts rating
3
9
1
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.93 → 3.93
Recent analyst moves
  • = Reiterate2026-08-05
    RBC Capital
    Outperform
  • = Reiterate2026-07-24
    Citigroup
    Market Outperform
  • = Reiterate2026-07-08
    Barclays
    Underweight
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    20.54x
    3.94x44.30x
    Cheap
  • Forward P/E
    16.30x
    4.64x37.16x
    Cheap
  • EV / EBITDA
    13.31x
    3.77x30.13x
    Cheap
  • FCF Yield
    7.1%
    -138.2%7.8%
    Strong
  • Revenue Growth YoY
    15.9%
    -56.9%93.8%
    Near median
  • EPS Growth YoY
    25.6%
    -160.1%130.2%
    Above average
  • Gross Margin
    32.4%
    12.8%90.7%
    Below average
  • ROIC
    9.0%
    -155.3%16.0%
    Strong
  • Net Debt / EBITDA
    0.06x
    0.60x5.10x
    Low debt
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    6.20
    -38.7417.53
    Strong
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-05-05 data

Company Overview

Addus HomeCare Corporation provides home care services through three segments: personal care, hospice care, and home health care. In Q1 fiscal 2026, the personal care segment generated $281.1 million, representing 77.3% of revenue, compared with $65.8 million, or 18.1%, for hospice care and $16.7 million, or 4.6%, for home health care; therefore, the company primarily depends on billable personal care hours, while also benefiting from referrals between care lines in overlapping markets.

In Q2 fiscal 2026, revenue was $377.4 million, gross profit was $121.6 million, net income was $27.6 million, and earnings per share were $1.49. These figures represent a gross margin of approximately 32.2% and a net income margin of approximately 7.3%, compared with revenue of $363.6 million, gross profit of $115.9 million, net income of $25.1 million, and earnings per share of $1.36 in Q1 fiscal 2026.

On a trailing twelve-month basis ending in fiscal 2026, Addus recorded revenue of $1.5 billion, gross profit of $477.8 million, net income of $105.3 million, and earnings per share of approximately $5.70. By comparison, it ended fiscal 2025 with revenue of $1.4 billion, gross profit of $461.9 million, net income of $95.9 million, and earnings per share of $5.22, demonstrating continued earnings growth alongside revenue expansion.

What's Driving the Stock

  • Q2 fiscal 2026 revenue rose to $377.4 million from $363.6 million in Q1 fiscal 2026, while net income increased to $27.6 million from $25.1 million and earnings per share rose to $1.49 from $1.36.
  • In Q1 fiscal 2026, personal care revenue grew 8.8% to $281.1 million, with same-store growth of 6.5%, supported by a 2.2% increase in same-store personal care hours and rate increases of 3.9% in Illinois effective January 1, 2026, and 9.9% in Texas effective September 1, 2025.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • The hospice care segment achieved same-store growth of 7.7% in Q1 fiscal 2026, and average daily census increased 8.2% to 3,804 patients from 3,515 patients in the corresponding period, with more than 25% of its admissions in New Mexico and Tennessee coming from Addus Home Health operations.
  • On May 1, 2026, the company closed the acquisition of HomeCourt Home Care’s personal care operations in Indiana, which serve approximately 240 clients and generate annual revenue of approximately $9.7 million. It also signed a definitive agreement to acquire additional operations of a similar size, which could increase the combined revenue base in the state to just under $20 million following a closing subject to regulatory approvals.
  • Operating cash flow was $52.4 million in Q1 fiscal 2026, cash was $103.1 million as of March 31, 2026, and bank debt declined by $30 million since the end of Q4 fiscal 2025 to $94.3 million. The company retained $547.8 million of availability under a $650 million revolving credit facility, supporting its plan to pursue acquisition opportunities.
  • The Caregiver application reached Illinois and some New Mexico branches, and Addus rolled it out in Texas during Q1 fiscal 2026, where more than 10% of caregivers adopted it within the first few days to a week. Management links the application to improving the utilization of authorized hours, making additional hours available, and increasing the percentage of hours actually provided.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +The results combine revenue growth with improved profitability; in Q1 fiscal 2026, revenue increased 7.7%, adjusted earnings per share rose 14.1% to $1.62, and adjusted earnings before interest, taxes, depreciation, and amortization increased 9.7% to $44.5 million, with its margin rising to 12.2% from 12.0%.
    • +Addus has clear financing capacity for expansion, with cash of $103.1 million and bank debt of $94.3 million as of March 31, 2026, after which the company repaid an additional $10 million on the revolving facility during Q2 fiscal 2026 through the date of the May 5, 2026 call.
    • +Hospice care growth and implementation of the Bridge program provide partial diversification away from personal care; average daily census increased 8.2% in Q1 fiscal 2026, and home health care operations became the source of more than 25% of hospice care admissions in New Mexico and Tennessee.
    • +Expansion in Indiana supports the strategy of increasing geographic density because HomeCourt adds approximately $9.7 million in annual revenue and 240 clients, while the second transaction could add a similar amount of scale without the expected need for additional regional management layers.

    ▼ Selling Case6 pts

    • −Revenue concentration represents a material risk, as the personal care segment generated 77.3% of Q1 fiscal 2026 revenue, and management described Illinois as the company’s largest market; therefore, rate or volume changes in this segment or market could significantly affect consolidated results.
    • −Personal care results are tied to Medicaid decisions and state budgets, as the Illinois rate increase added approximately $17.5 million in annual revenue, while the distribution mechanism for New Mexico’s $10 million in funding for home- and community-based services had not been clarified as of the May 5, 2026 call. The 80-20 provision of the Medicaid Access Rule also remained in place, despite management’s expectation that it would be repealed, and its implementation does not affect current performance because it was still several years away.
    • −Organic home health care revenue declined 6.6% in Q1 fiscal 2026, and the segment remained small at $16.7 million, or 4.6% of revenue. Although admissions, visits, and census improved sequentially, volume growth remained the focus after restoring target margins.
    • −The expansion plan partly depends on executing and integrating acquisitions; the second Indiana transaction was still subject to regulatory approvals, while management was evaluating larger opportunities comparable in size to the Gentiva transaction. A failure to close or weak integration could limit geographic density and the expected return on capital.
    • −The loss of approximately $1.5 million in revenue due to the January 2026 storms demonstrates the sensitivity of billable hours to visit disruptions, even with some visits rescheduled. Personal care census also declined slightly sequentially in Q1 fiscal 2026, although management indicated that the trend improved in March 2026.
    • −One insider sale was recorded through June 22, 2026, with three-month net sales of $27,005.76 and no recorded purchases. This is a weak trading signal on its own because insider sales may be prearranged unless the data states otherwise.

    Valuation

    The average analyst price target is $115, with a wide range of $96 to $134 and a consensus rating of “Buy,” while the average is below the 52-week range high of $124.44 and above its low of $87.95. The highest target of $134 indicates a more optimistic scenario than the 52-week range high, while the lowest target of $96 reflects meaningful caution regarding Medicaid risks, personal care concentration, and acquisition execution.

    BuyAnalyst target: $115(-1.8%)

    Figures in the text are as of 2026-09-01; the live price is shown at the top of the page.

    FAQ

    How did Addus perform in Q2 fiscal 2026?

    Q2 fiscal 2026 revenue was approximately $377.4 million, compared with $363.6 million in Q1 fiscal 2026. Gross profit increased to $121.6 million from $115.9 million, representing a gross margin of approximately 32.2%. Net income also increased to $27.6 million and earnings per share to $1.49, compared with $25.1 million and $1.36 in the previous quarter.

    What is ADUS’s largest source of revenue?

    Personal care is the largest business, generating $281.1 million and accounting for 77.3% of Q1 fiscal 2026 revenue. Hospice care ranked second with revenue of $65.8 million and an 18.1% share, followed by home health care with revenue of $16.7 million and a 4.6% share. Personal care revenue grew 8.8% overall and 6.5% on a same-store basis compared with Q1 fiscal 2025.

    What do the two Indiana transactions add to Addus?

    On May 1, 2026, Addus closed the acquisition of HomeCourt Home Care’s personal care operations in Fort Wayne. These operations serve approximately 240 clients and generate estimated annual revenue of approximately $9.7 million. The company also signed a definitive agreement to acquire other operations of a similar size, which could increase its combined revenue in Indiana to just under $20 million after obtaining regulatory approvals.

    How does the Caregiver application support personal care growth?

    The application was in use in Illinois and was rolled out in some New Mexico branches and in Texas during Q1 fiscal 2026. In Texas, more than 10% of caregivers downloaded it within the first few days to a week after launch. Addus uses it to display the remaining hours under an authorization, make additional hours available to caregivers, and improve communication and the percentage of authorized hours actually provided.

    What are the main regulatory risks facing Addus?

    Personal care depends significantly on Medicaid rates and state budgets, and the Illinois rate increase effective January 1, 2026, added approximately $17.5 million in annual revenue. In New Mexico, the budget included an additional $10 million for home- and community-based services, but the distribution method had not been determined as of the May 5, 2026 call. The 80-20 provision of the Medicaid Access Rule also remained in place, despite management’s belief that it would be repealed, and it had no impact on current financial performance because implementation was still several years away.

    Does Addus have the financial capacity to fund additional acquisitions?

    Operating cash flow was $52.4 million in Q1 fiscal 2026, compared with $18.9 million in Q1 fiscal 2025. As of March 31, 2026, the company held $103.1 million in cash and reduced its bank debt to $94.3 million after repaying $30 million during the quarter. It also had $547.8 million of available liquidity under a $650 million revolving credit facility, then repaid an additional $10 million during Q2 fiscal 2026 through the date of the May 5, 2026 call.